Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and Atorvastatin in Hepatitis C
NCT00446940Phase 2Completed
- Start
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hepatitis C (HCV) comparing Rosuvastatin Arm with Atorvastatin Arm (2 arms). Primary endpoint: Hepatitis C Virus RNA at 16 weeks. Started Dec 2006; status: completed.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00446940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446940.